Explore 25B-NBOTFM | PiHKAL · info

Exploring 25B-NBOTFM. To explore a different substance…

Names

25B-NBOTFM
N-(2-Trifluoromethoxybenzyl)-4-bromo-2,5-dimethoxyphenethylamine

IUPAC names

2-(4-Bromo-2,5-dimethoxyphenyl)-N-{[2-(trifluoromethoxy)phenyl]methyl}ethan-1-amine
2-(4-Bromo-2,5-dimethoxyphenyl)-N-[2-(trifluoromethoxy)benzyl]ethan-1-amine

ID 386 · Formula C₁₈H₁₉BrF₃NO₃ · Molecular weight 434.248

InChI InChI=1S/C18H19BrF3NO3/c1-24-16-10-14(19)17(25-2)9-12(16)7-8-23-11-13-5-3-4-6-15(13)26-18(20,21)22/h3-6,9-10,23H,7-8,11H2,1-2H3

InChI Key IKOAAJJMMMCETP-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES COc1cc(Br)c(cc1CCNCc1ccccc1OC(F)(F)F)OC

Heim, R. Synthesis and pharmacology of potent 5-HT_2A receptor agonists with N-2-methoxybenzyl partial structure SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. 3.9 MB. #232 In German. MS,NMR,IR

Heim, R; Pertz, HH; Elz, S. Partial 5-HT_2A-receptor agonists of the phenylethanamine series: Effect of a trifluoromethyl substituent Arch. Pharm. Pharm. Med. Chem., 3 May 2000, 333 (Suppl. 2), 45. 542 kB. #4 Poster abstract

Leth-Petersen, S; Bundgaard, C; Hansen, M; Carnerup, MA; Kehler, J; Kristensen, JL. Correlating the metabolic stability of psychedelic 5-HT_2A agonists with anecdotal reports of human oral bioavailability Neurochem. Res., 12 Feb 2014, 39 (10), 2018-2023. 625 kB. https://doi.org/10.1007/s11064-014-1253-y #4e

7 Dec 2019 · · Isomer Design